Literature DB >> 19553550

Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs.

M P Alves1, L Guzylack-Piriou, V Juillard, J-C Audonnet, T Doel, H Dawson, W T Golde, H Gerber, N Peduto, K C McCullough, A Summerfield.   

Abstract

Emergency vaccination as part of the control strategies against foot-and-mouth disease virus (FMDV) has the potential to limit virus spread and reduce large-scale culling. To reduce the time between vaccination and the onset of immunity, immunostimulatory CpG was tested for its capacity to promote early protection against FMDV challenge in pigs. To this end, CpG 2142, an efficient inducer of alpha interferon, was injected intramuscularly. Increased transcription of Mx1, OAS, and IRF-7 was identified as a sensitive measurement of CpG-induced innate immunity, with increased levels detectable to at least 4 days after injection of CpG formulated with Emulsigen. Despite this, CpG combined with an FMD vaccine did not promote protection. Pigs vaccinated 2 days before challenge had disease development, which was at least as acute as that of unvaccinated controls. All pigs vaccinated 7 days before challenge were protected without a noticeable effect of CpG. In summary, our results demonstrate the caution required when translating findings from mouse models to natural hosts of FMDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553550      PMCID: PMC2725537          DOI: 10.1128/CVI.00018-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine.

Authors:  P V Barnett; S J Cox; N Aggarwal; H Gerber; K C McCullough
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

Review 3.  Targeting the innate immune response with improved vaccine adjuvants.

Authors:  Achal Pashine; Nicholas M Valiante; Jeffrey B Ulmer
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

4.  Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.

Authors:  Marvin J Grubman
Journal:  Biologicals       Date:  2005-11-14       Impact factor: 1.856

5.  Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA.

Authors:  Isabelle E Vincent; Carole Balmelli; Brian Meehan; Gordon Allan; Artur Summerfield; Kenneth C McCullough
Journal:  Immunology       Date:  2006-10-13       Impact factor: 7.397

6.  Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides.

Authors:  Søren Kamstrup; Tine Holland Frimann; Annette Malene Barfoed
Journal:  Antiviral Res       Date:  2006-04-18       Impact factor: 5.970

7.  Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.

Authors:  M P Alves; V Neuhaus; L Guzylack-Piriou; N Ruggli; K C McCullough; A Summerfield
Journal:  Gene Ther       Date:  2007-03-01       Impact factor: 5.250

8.  CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.

Authors:  D G Cerys Rees; Amanda J Gates; Michael Green; Lin Eastaugh; Roman A Lukaszewski; Kate F Griffin; Arthur M Krieg; Richard W Titball
Journal:  Antiviral Res       Date:  2005-02       Impact factor: 5.970

9.  Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.

Authors:  Sonia de Avila Botton; Mario C S Brum; Elida Bautista; Marla Koster; Rudi Weiblen; William T Golde; Marvin J Grubman
Journal:  Vaccine       Date:  2006-02-20       Impact factor: 3.641

10.  A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.

Authors:  Ali M Harandi; Kristina Eriksson; Jan Holmgren
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  14 in total

1.  Anti-foot-and-mouth disease virus effects of Chinese herbal kombucha in vivo.

Authors:  Naifang Fu; Juncai Wu; Lv Lv; Jijun He; Shengjun Jiang
Journal:  Braz J Microbiol       Date:  2015-10-09       Impact factor: 2.476

2.  Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  Virol J       Date:  2012-03-14       Impact factor: 4.099

3.  Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals.

Authors:  Noah D Cohen; Jessica R Bourquin; Angela I Bordin; Kyle R Kuskie; Courtney N Brake; Kaytee B Weaver; Mei Liu; M Julia B Felippe; Michael H Kogut
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

4.  Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.

Authors:  Giselle Rangel; Juan Bárcena; Noelia Moreno; Carlos P Mata; José R Castón; Alí Alejo; Esther Blanco
Journal:  Vaccines (Basel)       Date:  2021-05-07

5.  Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs.

Authors:  Sang-Hyun Park; Seo-Yong Lee; Jae-Seok Kim; Ah-Young Kim; Sun-Young Park; Ji-Hye Lee; Mijung Lee; Hyejin Kim; Sim-In Lee; Na-Young Kang; Jung-Won Park; Su-Mi Kim; Jong-Hyeon Park; Young-Joon Ko
Journal:  Vaccines (Basel)       Date:  2021-06-02

6.  Efficient sensing of infected cells in absence of virus particles by plasmacytoid dendritic cells is blocked by the viral ribonuclease E(rns.).

Authors:  Sylvie Python; Markus Gerber; Rolf Suter; Nicolas Ruggli; Artur Summerfield
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

7.  The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.

Authors:  Nevi Parameswaran; George C Russell; Kathryn Bartley; Dawn M Grant; David Deane; Helen Todd; Mark P Dagleish; David M Haig
Journal:  Vet Res       Date:  2014-05-27       Impact factor: 3.683

8.  Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.

Authors:  Seo-Yong Lee; Yeo-Joo Lee; Rae-Hyung Kim; Jeong-Nam Park; Min-Eun Park; Mi-Kyeong Ko; Joo-Hyung Choi; Jia-Qi Chu; Kwang-Nyeong Lee; Su-Mi Kim; Dongseob Tark; Hyang-Sim Lee; Young-Joon Ko; Min-Goo Seo; Jung-Won Park; Byounghan Kim; Myoung-Heon Lee; Jong-Soo Lee; Jong-Hyeon Park
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

9.  Targeting of the Nasal Mucosa by Japanese Encephalitis Virus for Non-Vector-Borne Transmission.

Authors:  Roman O Braun; Panagiota Milona; Obdulio García-Nicolás; Marta Lewandowska; Ronald Dijkman; Marco P Alves; Artur Summerfield
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

Review 10.  Cell mediated innate responses of cattle and swine are diverse during foot-and-mouth disease virus (FMDV) infection: a unique landscape of innate immunity.

Authors:  Felix N Toka; William T Golde
Journal:  Immunol Lett       Date:  2013-05-30       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.